BDNF and depressive symptom measurement: In conclusion, our current study demonstrated that the presence of the functional BDNF Val66Met polymorphism was associated with depression in T2DM by decreasing the serum BDNF levels, suggesting that increased BDNF levels may be a therapeutic potential in depression patients with T2DM.